![Douglas Blankenship](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas Blankenship
Net worth: 462 $ as of 2024-06-29
Network origin in Douglas Blankenship first degree
Entity | Entity type | Industry | |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
183
| Subsidiary | Biotechnology | 183 |
Roche Pharmaceuticals, Inc.
![]() Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.
17
| Subsidiary | Miscellaneous Commercial Services | 17 |
Subsidiary | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Douglas Blankenship via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member President | |
AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel Director/Board Member Corporate Officer/Principal | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Director/Board Member Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Founder Founder | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Roche Group
![]() Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BEIGENE, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
University of California | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Altrubio, Inc.
![]() Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Chairman Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
AMYRIS, INC. | Chemicals: Specialty | Director/Board Member Chairman General Counsel | |
Gyroscope Therapeutics Ltd.
![]() Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Alumis, Inc.
![]() Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Chief Executive Officer | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Compliance Officer | |
University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
University of Southern California
![]() University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
University of Michigan | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
23andMe, Inc.
![]() 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
23ANDME HOLDING CO. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Director/Board Member President Chief Tech/Sci/R&D Officer | |
Boston University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
Acerta Pharma BV
![]() Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Crescendo Bioscience LLC
![]() Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Sales & Marketing Corporate Officer/Principal | |
LIQUIDIA CORPORATION | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer | |
RELYPSA INC | Pharmaceuticals: Major | President Director/Board Member | |
Iowa State University | College/University | Doctorate Degree Doctorate Degree | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer |
Statistics
International
United States | 41 |
United Kingdom | 5 |
Switzerland | 3 |
Cayman Islands | 2 |
Japan | 2 |
Sectoral
Health Technology | 32 |
Consumer Services | 14 |
Finance | 3 |
Commercial Services | 3 |
Retail Trade | 2 |
Operational
Director/Board Member | 399 |
Corporate Officer/Principal | 260 |
Independent Dir/Board Member | 125 |
Chief Tech/Sci/R&D Officer | 102 |
Undergraduate Degree | 79 |
Most connected contacts
Insiders | |
---|---|
André S. Hoffmann | 52 |
Charlie Sanders | 38 |
J. Kenneth Charles Knowles | 29 |
Patrick Yang | 28 |
William Burns | 27 |
Richard Scheller | 27 |
Debra Reed-Klages | 26 |
Tsontcho Ianchulev | 21 |
Joseph McCracken | 20 |
Arthur Levinson | 19 |
Alfred Novak | 19 |
Pamela Klein | 19 |
Daniel O'Day | 19 |
Pascal Soriot | 18 |
Roger Jeffs | 18 |
- Stock Market
- Insiders
- Douglas Blankenship
- Company connections